AI
Moxi performs delivery tasks in hospitals, like bringing supplies, delivering lab samples and distributing personal protective equipment.
This new infusion of cash brings the company's total valuation to $1.2 billion.
This marks Aidoc's second FDA 510(k) so far this year.
The multiyear agreement will focus on speeding clinical trials and drug development in oncology and nonalcoholic steatohepatitis.
The startup said it expects its imaging analysis tool to receive FDA clearance in the coming months.
The software automatically flags cases of pneumothorax, or a collapsed lung, on X-rays for more efficient triage.
Oli uses sensors and AI to identify mothers who are at high risk of developing abnormal postpartum haemorrhage.
Also: Digital mental health company Brightside Health scores $50 million, and Qure.ai brings in $40 million for its imaging algorithms.
The Series C comes about two years after another $150 million raise.
The algorithm analyses EHR data and learns treatment patterns of type 2 diabetes patients.